Connect Sign In
Chlamydia trachomatis Culture
Ordering Recommendation
Not recommended for routine detection of Chlamydia trachomatis (CT). Use to assess suspected treatment failure. May be considered for anatomic locations for which amplified testing has not been validated.
New York DOH Approval Status
Specimen Required
Cervical, eye, rectal, urethral swab, or peritoneal fluid. Also acceptable for newborns: Nasopharyngeal aspirate, swab or washing.
Immediately place swab, fluid, or washing in 3 mL universal transport medium such as M4, M4RT, M5, M6, UniTranz-RT, or UTM (ARUP supply #12884). Available online through eSupply using ARUP Connect or contact ARUP Client Services at (800) 522-2787.
Frozen on dry ice.
Urine. Specimens in any transport media other than indicated. Calcium alginate, dry, or wood swabs.
Specimen source preferred.
Ambient: 1 hour; Refrigerated: 48 hours; Frozen at -20°C: Unacceptable; Frozen at -70°C: 1 month
Methodology
Cell Culture/Immunofluorescence
Performed
Sun-Sat
Reported
2-5 days
Reference Interval
Culture negative for Chlamydia trachomatis.
Interpretive Data
FDA
Note
Nucleic acid amplification testing is recommended for detection of Chlamydia trachomatis from endocervical or urethral specimens. Refer to Chlamydia trachomatis by Transcription-Medicated Amplification (TMA) (ARUP test code 0060243). Specimen must be collected and transported with test-specific kit (ARUP supply #55224).
Positive Chlamydia cultures are confirmed for trachomatis by Chlamydia trachomatis by Transcription-Mediated Amplification (TMA) at no additional charge. Some specimen types acceptable for the Chlamydia trachomatis Culture may require a disclaimer for the TMA confirmation assay.
Hotline History
CPT Codes
87110; 87140
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 0060859 | C. trachomatis Culture | 6349-5 |
| 0060865 | C. trachomatis Source | 31208-2 |
Aliases
- C. Trachomatis
- Chlamydia Trachomatis
